Vericel (VCEL) Gross Profit (2011 - 2026)
Vericel (VCEL) reported Gross Profit of $49.3 million for Q1 2026, up 35.82% on a YoY basis from $36.3 million in Q1 2025, and down 32.63% sequentially from $73.1 million in Q4 2025.
Vericel (VCEL) Gross Profit (2011 - 2026) Analysis & Trends
Vericel (VCEL) has 16 years of Gross Profit data on file, last reported at $49.3 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 35.82% year-over-year to $49.3 million; the trailing twelve-month figure through Mar 2026 stood at $218.6 million (up 26.33% YoY), and the FY2025 full-year result was $205.6 million, up 19.46% from the prior year.
- Gross Profit declined to $49.3 million in Q1 2026, from $73.1 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $73.1 million in Q4 2025 to a low of $22.9 million in Q2 2022.
- A 5-year average of $39.5 million and a median of $36.6 million in 2024 frame the typical range for Gross Profit.
- Across the five-year window, Gross Profit fell 15.07% in 2022 and surged 36.09% in 2024, its largest moves.
- Tracing VCEL's Gross Profit over 5 years: stood at $38.2 million in 2022, then climbed by 26.82% to $48.5 million in 2023, then climbed by 20.6% to $58.5 million in 2024, then gained by 25.01% to $73.1 million in 2025, then plunged by 32.63% to $49.3 million in 2026.
- Business Quant data shows VCEL's Gross Profit at $49.3 million in Q1 2026, $73.1 million in Q4 2025, and $49.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.27 Mn |
| Mar 31, 2026 | 49.27 Mn |
| Dec 31, 2025 | 73.13 Mn |
| Dec 31, 2025 | 73.13 Mn |
| Sep 30, 2025 | 49.59 Mn |
| Sep 30, 2025 | 49.59 Mn |
| Jun 30, 2025 | 46.61 Mn |
| Jun 30, 2025 | 46.61 Mn |
| Mar 31, 2025 | 36.27 Mn |
| Mar 31, 2025 | 36.27 Mn |
| Dec 31, 2024 | 58.50 Mn |
| Dec 31, 2024 | 58.50 Mn |
| Sep 30, 2024 | 41.65 Mn |
| Sep 30, 2024 | 41.65 Mn |
| Jun 30, 2024 | 36.60 Mn |
| Jun 30, 2024 | 36.60 Mn |
| Mar 31, 2024 | 35.35 Mn |
| Mar 31, 2024 | 35.35 Mn |
| Dec 31, 2023 | 48.51 Mn |
| Dec 31, 2023 | 48.51 Mn |